8-OH-DPAT Induces Compulsive-like Deficit in Spontaneous Alternation Behavior: Reversal by MDMA but Not Citalopram
- 6 June 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 10 (7) , 3094-3100
Abstract
Rodents exhibit natural exploratory behaviors, which can be measured by the spontaneous alternation behavior (SAB) test. Perseverance in this test induced by the 5-hydroxytrypamine 1A receptor (5-HT1AR) agonist, 8-hydroxy-2-dipropylaminotetralin (8-OH-DPAT), resembles compulsive behaviors observed in humans and manifests as reduced alternation ratio. This study characterized 8-OH-DPAT-induced perseverance in the SAB test in C57BL/6JOlaHsd male mice by co-administration of WAY100635, citalopram and the 5-HT releasing agent 3,4-methylenedioxymethamphetamine (MDMA) to deepen the understanding of 5-HT-dependent mechanisms. The 5-HT1AR mechanism of 8-OH-DPAT (1.0 mg/kg, p<0.01) on perseverance was confirmed by co-administration of the 5-HT1AR antagonist WAY100635 (2.0 mg/kg, p<0.05), which attenuated the effects of 8-OH-DPAT. Such effects could also be reversed by MDMA (1.0 mg/kg, p<0.05; 10.0 mg/kg, p<0.001) but not citalopram. These findings confirm the importance of 5-HT in regulating perseverative behavior. Future investigations are required to determine the predictive validity of the 8-OH-DPAT-disrupted SAB as an inducible mouse model of compulsivity.Keywords
Funding Information
- Lundbeck Foundation (R263-2017-3000)
This publication has 52 references indexed in Scilit:
- Animal models of obsessive-compulsive disorder: Exploring pharmacology and neural substratesNeuroscience & Biobehavioral Reviews, 2012
- Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: comparison with sertralineJournal of Psychopharmacology, 2010
- Pharmacological or Genetic Inactivation of the Serotonin Transporter Improves Reversal Learning in MiceCerebral Cortex, 2009
- Differential effects of acute and repeated citalopram in mouse models of anxiety and depressionInternational Journal of Neuropsychopharmacology, 2009
- Effects of bilateral lesions in thalamic reticular nucleus and orbitofrontal cortex in a T-maze perseverative model produced by 8-OH-DPAT in ratsBehavioural Brain Research, 2009
- Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension testsBehavioural Brain Research, 2009
- Differential Contributions of Dopamine D1, D2, and D3 Receptors to MDMA-Induced Effects on Locomotor Behavior Patterns in MiceNeuropsychopharmacology, 2006
- Toward brain imaging of serotonin 5-HT1A autoreceptor internalizationNeuroImage, 2004
- Current advances and trends in the treatment of depressionTrends in Pharmacological Sciences, 1994
- Cognitive therapy for obsessive-compulsive disorderBehaviour Research and Therapy, 1994